Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2000
10/26/2000WO2000062620A2 Transformed cells useful for the control of pests
10/26/2000WO2000062615A1 Neuropeptides and their use for pest control
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000020112A3 Chemical constructs and their uses
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370259A1 Pyrrolidincarbonylamino cyclic disulfides
10/26/2000CA2367938A1 Peptides and the use thereof to control pests
10/26/2000CA2365949A1 Adhesion modulatory peptides and methods for use
10/26/2000CA2365220A1 Transformed cells useful for the control of pests
10/25/2000EP1046650A1 PEPTIDES, METHOD FOR ASSAYING HUMAN PEPSINOGEN II or HUMAN PEPSIN II, AND ASSAYING KIT
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/25/2000EP1045858A1 Anti-cryptococcal peptides
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000CN1270960A Process for preparing growth hormone cinogenic agent
10/25/2000CN1057773C N-protection aspartic sweet piptide preparation method
10/25/2000CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders
10/24/2000US6136956 Fibrous assembly of peptide lipid and method for the preparation thereof
10/24/2000US6136834 Tetrazole compounds and pharmaceutical agents containing such derivative
10/24/2000US6136800 Steroids
10/24/2000US6136798 Compounds inhibiting the association of the PDGF receptor and phosphatidylinositol 3-kinase and their use
10/24/2000US6136788 Pharmaceutical preparation for the therapy of immune deficiency conditions
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136269 Combinatorial kit for polymer synthesis
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061789A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000WO2000061631A1 Modified pentapeptide antagonists of the atrial natriuretic peptide clearance receptor
10/19/2000WO2000061609A2 Prodrugs of thrombin inhibitors
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061577A1 Prodrugs of thrombin inhibitors
10/19/2000WO2000061574A2 Method for producing thiophenyl-amidines
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061195A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000CA2372171A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2370267A1 Prodrugs of thrombin inhibitors
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2369267A1 Method for producing amidines
10/19/2000CA2368830A1 Prodrugs of thrombin inhibitors
10/19/2000CA2366671A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000CA2360318A1 A second mammalian tankyrase
10/18/2000EP1044215A1 Anti-inflammatory phenylalanine derivatives
10/18/2000CN1057519C Production of beta-hydroxyalkylamides
10/17/2000US6133463 For use in cosmetic and dermatological compositions for treating or caring for the skin
10/17/2000US6133418 Synthetic peptide inhibitors of HIV transmission
10/17/2000US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity
10/17/2000US6133256 Selective factor Xa inhibitors
10/17/2000US6132697 Radiopharmaceutical compositions capable of localizing at sites of thrombus
10/17/2000CA2177357C Pna-dna-pna chimeric macromolecules
10/12/2000WO2000059931A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use
10/12/2000WO2000059929A1 Macrocyclic peptides active against the hepatitis c virus
10/12/2000WO2000059928A1 Chemokine-derived synthetic peptides
10/12/2000WO2000059925A1 A process for the production of glutamine derivatives and glutamine containing molecules
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059867A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties
10/12/2000WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000WO2000005250A9 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2368387A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000CA2365970A1 Chemokine-derived synthetic peptides
10/12/2000CA2364512A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use
10/11/2000EP1043332A1 Dipeptides comprising cyclopentan-beta-amino acids
10/11/2000EP1043322A1 Vitamin e derivatives
10/11/2000EP1042964A1 Sweetener composition
10/11/2000EP1042963A1 Granular sweetener
10/11/2000EP1042359A1 Kappa receptor opioid peptides
10/11/2000EP1042288A1 Tripeptidyl peptidase inhibitors
10/11/2000EP1042286A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
10/11/2000EP0831100B1 Novel peptide derivatives
10/11/2000CN1269806A Piptides containing arginine mimetic for treatment of bone metabolic disorders, their production and drugs containing these compounds
10/11/2000CN1269795A Method for preparing alkyloxy furnanone derivatives, compounds obtained by said method and use of said compounds
10/11/2000CN1269781A Method of purifying and recovering sweetener
10/11/2000CN1269364A Somatotropin releasing peptide
10/10/2000US6130315 Substrates in which the scissile amide bond has been replaced by an activated electrophilic ketone moiety; antiinflammatory agents; antiproliferative/anticarcinogenic/antiarthritic agents; treatment of autoimmune diseases
10/10/2000US6130204 Peptides
10/10/2000US6129942 With a conjugate base derived by deprotonation of an acidic sweetener, such as saccharin, acesulfame, cyclamic acid and glycyrrhizic acid
10/10/2000CA2020346C Antibiotic ge 2270 factors a1, a2, a3 and h
10/05/2000WO2000058478A1 MICROBIOLOGICAL PRODUCTION METHOD FOR α-L-ASPARTYL-L-PHENYLALANINE
10/05/2000WO2000058347A1 Cosmetic or dermopharmaceutical compositions containing tripeptide n-biotinyl-gly-his-lys for the prevention, reduction or suppression of hair loss and stimulation of regrowth
10/05/2000WO2000058346A1 N-sulfonyl-dipeptide derivatives, production and use thereof in therapy
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000DE19909373A1 Neue PNA-Monomere, daraus resultierende PNA-Oligomere und deren Verwendung New PNA monomers, resulting PNA oligomers and their use
10/05/2000CA2365594A1 Microbiological production method for .alpha.-l-aspartyl-l-phenylalanine
10/04/2000EP1041082A1 Process of peptidic synthesis starting from N-carboxyanhydride amino acids
10/04/2000EP1040119A2 Hemiasterlin analogs
10/04/2000EP1040096A1 Neuroprotective agents
10/04/2000EP1039923A1 Gamma-conopeptides
10/04/2000EP1039886A1 Hiv/fiv protease inhibitors having a small p3 residue
10/04/2000EP1039804A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
10/04/2000CN1057095C Novel peptides, prepn. and use thereof
10/03/2000US6127569 Crystallization of α-L-aspartyl-L-phenylalanine methyl ester
10/03/2000US6127391 Compounds with growth hormone releasing properties
10/03/2000US6127341 Aminomethyl-n-(1-((2-(2-thienyl)-1-(1-carbamoyl-5 -aminopentylcarbamoyl)ethyl)-n-methylcarbamoyl)-2-(2 -napthyl)ethyl)benzamide, for example; administering to stimulate growth, milk or wool production in animals
10/03/2000US6127340 Espcecially thrombin, in which the p1-p2 natural amide linkage is replaced by another bond; inhibiting coagulation of blood in a container; treatment or prevention of thrombosis
10/03/2000US6127339 Peptide for binding thereto a low density lipoprotein
10/03/2000US6127333 Conjugates useful in the treatment of prostate cancer
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
10/03/2000CA2000342C Novel peptidase inhibitors
10/03/2000CA1341106C Conformationally stabilized cell adhesion peptides